Tetraspanins, including TSPAN18, are integral membrane proteins characterized by their four transmembrane domains. These proteins are involved in a wide variety of cellular processes, including cell development, activation, growth, and motility, largely due to their ability to associate with other proteins and form complex networks known as tetraspanin-enriched microdomains (TEMs). These domains serve as platforms for signal transduction, influencing the activities of associated proteins. Therefore, any molecule that could interact with TSPAN18 or associated proteins in a way that promotes these activities might be considered a potential "TSPAN18 Activator".
It's crucial to note that these activators would likely need to be able to interact with the cellular membrane in order to influence the function of TSPAN18, given its location within the membrane. Activators could potentially function through direct interaction with TSPAN18 or through indirect mechanisms, such as modifying the activity of proteins associated with TSPAN18 or altering the lipid environment of the membrane to influence TSPAN18 function. It's also possible that these activators could function via intracellular mechanisms, potentially influencing the transcription or translation of TSPAN18. In all cases, the end result would be an upregulation of the normal function of TSPAN18, potentially leading to enhanced cell development, activation, growth, or motility.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which could indirectly trigger TSPAN18 by controlling the function of other proteins through phosphorylation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
By inhibiting protein synthesis, Cycloheximide could indirectly enable the activation of TSPAN18. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may indirectly stimulate TSPAN18 by influencing a variety of cellular processes, including immune response, inflammation, and cell growth and differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, Rapamycin may indirectly enable the activation of TSPAN18 by impacting protein synthesis and cell growth. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3Ks), which may indirectly trigger TSPAN18 by affecting cell growth and proliferation pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which could indirectly stimulate TSPAN18's activation by influencing the cellular response to stress and inflammation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits tyrosine kinases, which could indirectly trigger TSPAN18 by affecting multiple cellular signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which could indirectly enable the activation of TSPAN18 by influencing cell cycle progression and growth. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinases (JNKs), which could indirectly enable the activation of TSPAN18 by influencing the response to stress signals. | ||||||